News
Genentech wins FDA approval of drug to treat two blinding eye diseases
The drug, which will cost $2,190 per dose when sales begin in the coming weeks, ultimately can be dosed every one to four months.
Month: January 2022
News
OSF HealthCare partners with Elemeno Health to pilot point-of-care communication and training innovation for frontline nurses
PEORIA, Ill. and OAKLAND, Calif.: PEORIA, Ill. and OAKLAND, Calif., Jan. 31, 2022 /PRNewswire/ — Elemeno Health, the developer of a proprietary cloud-based solution for frontline health care teams, and OSF HealthCare, one of the largest health systems… […]
News
Biotech startup picked up rebounded CEO. Here’s why they think it’s a good match.
The new company’s approach, which is expected to enter an early-stage clinical trial this year, could both activate and suppress the immune system’s response to solid tumors.
News
Food Allergy Market Anticipated to Witness Massive Growth with a Tremendous CAGR of 13.5% in the 7MM for the Study Period of 2018-30 | DelveInsight
LAS VEGAS: LAS VEGAS, Jan. 31, 2022 /PRNewswire/ — DelveInsight’s Food Allergy Market Insights report proffers a detailed comprehension of Food Allergy market size by treatment, epidemiology, emerging therapies, Food Allergy market share of the indivi… […]
News
InsightRX Reports Record Growth in Platform Adoption by Health Systems and Biopharma Companies
SAN FRANCISCO: SAN FRANCISCO, Jan. 31, 2022 /PRNewswire/ — InsightRX, a healthcare technology company that provides precision dosing intelligence from clinical development to the point of care, announced a year of record growth in clinician users, act… […]
News
iBIO increases support for hands-on STEM with New Phase of its STEM Kit Program
CHICAGO: CHICAGO, Jan. 31, 2022 /PRNewswire/ — The Illinois Biotechnology Innovation Organization (iBIO), dedicated to inspiring the next generation of innovators and helping restore America’s leadership in technology education, today announced they w… […]
News
Roche, with an FDA nod for Vabysmo in hand, looks to challenge Regeneron’s dominant Eylea
Roche, with an FDA nod for Vabysmo in hand, looks to challenge Regeneron’s dominant Eylea
kdunleavy
Mon, 01/31/2022 – 09:52
[…]
News
Power Knot Collaborates with Microsoft to Create the First Solar Powered Biodigester
FREMONT, Calif.: FREMONT, Calif., Jan.31, 2022 /PRNewswire-PRWeb/ –Power Knot LLC, the market leader for onsite organic waste management solutions, announced today that Dubai Creative Group and Power Knot have collaborated with Microsoft Dubai to crea… […]
News
Collagen Matrix Inc. appoints Timothy J. Scannell, former President and Chief Operating Officer at Stryker, to its Board of Directors.
OAKLAND, N.J.: OAKLAND, N.J., Jan. 31, 2022 /PRNewswire/ — Collagen Matrix Inc., a leader in regenerative medicine, global manufacturer of collagen and mineral-based medical devices, and Linden Capital Partners portfolio company, announced today the a… […]
News
Applaud Medical Receives FDA Breakthrough Device Designation for the Company’s Acoustic Enhancer for Use in Conjunction With Ureteroscopy With Laser Lithotripsy (URS-LL) for the Fragmentation of Calcium-Based Kidney Stones
SAN FRANCISCO–(BUSINESS WIRE)–Applaud Medical, Inc. (Applaud), an emerging leader in the treatment of kidney stones, today announced that its Acoustic Enhancer technology has received Breakthrough Device designation from the U.S. Food and Drug Admini… […]
